Investor Presentaiton slide image

Investor Presentaiton

US Business at a glance 5th Largest Pharma Company in the US Generics Market Dermatology Segment . * • Largest generic dermatology company and amongst top 5 branded dermatology company in the US Comprehensive Portfolio Robust Pipeline Market Presence • • Wide basket of 561 ANDAs & 42 NDAs filed and 422 ANDAS & 39 NDAS approved across multiple therapies • 139 ANDAS & 3 NDAs pending FDA approval, including a combination of complex generics, FTF opportunities and pure generics • Presence in generics, branded & OTC segments Flexible Manufacturing Dosage Forms . Integrated manufacturer with flexibility for manufacturing onshore/offshore • Liquids, Creams, Ointments, Gels, Sprays, Injectable, Tablets, Capsules, Drug-Device combination © Sun Pharmaceutical Industries Limited. All Rights Reserved. SUN PHARMA * Source: Evaluate Pharma Estimates for 12 months ended Dec 2017 17
View entire presentation